SECUKINUMAB SIGNFICANTLY IMPROVES THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS IN PATIENTS PREVIOUSLY EXPOSED TO ANTI-TUMOUR NECROSIS FACTOR THERAPY AND ANTI-TUMOUR NECROSIS FACTOR-NAIVE PATIENTS: 52 WEEK RESULTS FROM THE PHASE III FUTURE 2 TRIAL

被引：0
|
作者：
McInnes, Iain [1 ]
Chinoy, Hector [2 ]
Kavanaugh, Arthur [3 ]
Wang, Zailong [4 ]
Mpofu, Shephard [5 ]
机构：
[1] Univ Glasgow, Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[2] Univ Manchester, Musculoskeletal Res Inflammat & Repair, Manchester, Lancs, England
[3] Univ Calif San Diego, Sch Med, Innovat Therapy, San Diego, CA 92103 USA
[4] Nova Pharmaceut Corp, Stat, E Hanover, NJ USA
[5] Novartis Pharmaceut, Clin Dev, Basel, Switzerland
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
195
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [21] ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS DOES NOT ATTENUATE CUTANEOUS TUMOUR NECROSIS FACTOR ACTIVITY FOLLOWING A TUBERCULIN SKIN TEST
    Byng-Maddick, Rachel
    Haas, Carolin
    Ehrenstein, Michael
    Noursadeghi, Mahdad
    RHEUMATOLOGY, 2016, 55 : 146 - 146
  • [22] Adherence to the new British Society for Rheumatology Psoriatic Arthritis guidelines for anti-tumour necrosis factor therapy
    Farquhar, K.
    Reid, M.
    Hanlon, S.
    Perry, M. E.
    SCOTTISH MEDICAL JOURNAL, 2015, 60 (03) : E14 - E15
  • [23] Soluble Biomarkers Predict Response to Anti-Tumour Necrosis Factor (TNF) Therapy in Psoriatic Arthritis (PsA)
    Chandran, Vinod
    Cook, Richard
    Pollock, Remy
    Pellett, Fawnda
    Shen, Hua
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1282 - 1283
  • [24] Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis
    Brown, Rachel A.
    Spina, Domenico
    Butt, Sayqa
    Summers, Gregory D.
    CLINICAL RHEUMATOLOGY, 2012, 31 (03) : 455 - 461
  • [25] Long-term effects of anti-tumour necrosis factor therapy on weight in patients with rheumatoid arthritis
    Rachel A. Brown
    Domenico Spina
    Sayqa Butt
    Gregory D. Summers
    Clinical Rheumatology, 2012, 31 : 455 - 461
  • [26] Opportunistic Infections in Patients Exposed to Anti-Tumour Necrosis Factor Therapy: Results From the British Society for Rheumatology Biologics Register
    Galloway, James B.
    Low, Audrey S. L.
    Mercer, Louise K.
    Dixon, William G.
    Ustianowski, Andrew
    Lunt, Mark
    Watson, Kath D.
    Hyrich, Kimme L.
    Symmons, Deborah P. M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S988 - S988
  • [27] Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy
    Park, S-J
    Jo, K-W.
    Yoo, B.
    Lee, C-K.
    Kim, Y-G.
    Yang, S-K.
    Byeon, J-S.
    Kim, K-J
    Ye, B. D.
    Park, S-H.
    Shim, T. S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (03) : 342 - 348
  • [28] Acute psychosis in three patients receiving anti-tumour necrosis factor-α therapy
    McGregor, L.
    Saunders, S. A.
    Hunter, J. A.
    Murphy, E.
    RHEUMATOLOGY, 2008, 47 (08) : 1254 - 1255
  • [29] BASDAI CHANGES IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR THERAPY
    Clarke, Laura
    Kay, Lesley
    RHEUMATOLOGY, 2010, 49 : I58 - I59
  • [30] Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's disease
    Mak, Joyce Wing Yan
    Tang, Whitney
    Yip, Terry Cheuk Fung
    Ran, Zhi Hua
    Wei, Shu Chen
    Ahuja, Vineet
    Kumar, Sudheer
    Leung, Wai Keung
    Hilmi, Ida
    Limsrivilai, Julajak
    Aniwan, Satimai
    Lam, Belsy C. Y.
    Chan, Kam Hon
    Ng, Ka Man
    Leung, Chi Man
    Li, Michael K. K.
    Lo, Fu Hang
    Sze, Alex Shun Fung
    Tsang, Steven Woon Choy
    Hui, Aric J.
    Hartono, Juanda Leo
    Ng, Siew C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (11-12) : 1195 - 1203
12345